TY - GEN
T1 - Fabrication and characterization of silica/Fe2.18Zn0.82O4 nanocomposites
AU - Taufiq, Ahmad
AU - Monica, Anindya Bella
AU - Nikmah, Ainun
AU - Hidayat, Arif
AU - Sunaryono,
AU - Hidayat, Nurul
AU - Susanto, Hendra
AU - Handoko, Erfan
N1 - Publisher Copyright:
© 2020 American Institute of Physics Inc.. All rights reserved.
PY - 2020/4/21
Y1 - 2020/4/21
N2 - In this paper, we report the fabrication and characterization of silica/Fe2.18Zn0.82O4 nanocomposites used as doxorubicin anti-cancer drug carrier. Silica/Fe2.18Zn0.82O4 nanocomposites were synthesized by using coprecipitation method followed by tetraethyl-orthosilicate hydrolysis process. The synthesis products were characterized by means of XRD, XRF, FTIR, UV Vis, and SEM. XRD characterization resulted in particle size of 7.14 nm. The presence of Si and Zn in the samples was confirmed from XRF characterization result: 49.2% for Si and 14.1% for Zn. Furthermore, functional groups of FTIR results also detected Si-O-Si bond in the wavelength of 1023 and 1091 cm-1. Based on the analysis of drug loading, silica/Fe2.18Zn0.82O4 nanocomposites had exemplary absorbance for doxorubicin as an anti-cancer drug. The release profile of the drug also showed the possibility of its use in medical application since release kinetic indicated stable drug dose in a relatively long period.
AB - In this paper, we report the fabrication and characterization of silica/Fe2.18Zn0.82O4 nanocomposites used as doxorubicin anti-cancer drug carrier. Silica/Fe2.18Zn0.82O4 nanocomposites were synthesized by using coprecipitation method followed by tetraethyl-orthosilicate hydrolysis process. The synthesis products were characterized by means of XRD, XRF, FTIR, UV Vis, and SEM. XRD characterization resulted in particle size of 7.14 nm. The presence of Si and Zn in the samples was confirmed from XRF characterization result: 49.2% for Si and 14.1% for Zn. Furthermore, functional groups of FTIR results also detected Si-O-Si bond in the wavelength of 1023 and 1091 cm-1. Based on the analysis of drug loading, silica/Fe2.18Zn0.82O4 nanocomposites had exemplary absorbance for doxorubicin as an anti-cancer drug. The release profile of the drug also showed the possibility of its use in medical application since release kinetic indicated stable drug dose in a relatively long period.
UR - http://www.scopus.com/inward/record.url?scp=85092573112&partnerID=8YFLogxK
U2 - 10.1063/5.0002465
DO - 10.1063/5.0002465
M3 - Conference contribution
AN - SCOPUS:85092573112
T3 - AIP Conference Proceedings
BT - International Conference on Life Science and Technology, ICoLiST 2019
A2 - Taufiq, Ahmad
A2 - Susanto, Hendra
A2 - Nur, Hadi
A2 - Aziz, Muhammad
A2 - Chang, Chuang-Rung
A2 - Lee, Hyohyemi
A2 - Diantoro, Markus
A2 - Mufti, Nandang
A2 - Malek, Nik Ahmad Nizam Nik
A2 - Wang, I. Ching
A2 - Iskandar, Djoko Tjahnono
A2 - Elbers, Gereon
A2 - Sunaryono, Sunaryono
A2 - Zubaidah, Siti
A2 - Sumari, Sumari
A2 - Aulanni'am, null
A2 - Nandiyanto, Asep Bayu
A2 - Wibowo, Indra
A2 - Handaya, Adeodatus Yuda
PB - American Institute of Physics Inc.
T2 - 2nd International Conference on Life Science and Technology, ICoLiST 2019
Y2 - 12 September 2019 through 13 September 2019
ER -